Xcout IntelNewcelX Ltd. competitors & alternatives
The 12 closest competitors and alternatives to NewcelX Ltd. among biotech companies — ranked by similarity to what NewcelX Ltd. actually does, not by market-cap band.
Subscribe to see NewcelX Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About NewcelX Ltd.
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
NewcelX Ltd. at a glance
NewcelX Ltd. is a biotech company headquartered in Kloten, Switzerland. It is publicly listed (NCEL) with a market capitalisation of $17.5M. Xcout tracks 23 named people at NewcelX Ltd., including Ronen Twito (Chief Executive Officer & Executive Chairman).
NewcelX Ltd. leadership
- Ronen TwitoChief Executive Officer & Executive Chairman
- Yossi Ben-YossefHonorary President & Strategic Consultant
- Omri HagaiChief Financial Officer
- Alexander ZwyerChief Business Officer & Executive Director
- Alex ZwyerDirector & Chief Business Officer
- Michel RevelDirector & Chief Scientific Officer
17 more named people on record for NewcelX Ltd., with roles, board committees and tenure — see the full roster →
Top 12 NewcelX Ltd. competitors
Ranked by semantic similarity — how close each company is to NewcelX Ltd. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Argo Therapeutics is a Swiss biotechnology company headquartered in Allschwil, Switzerland, focused on neurodegenerative-disease therapeutics.
Similar biotech company
BrainZell is a Swedish biotechnology company headquartered in Stockholm that develops human brain cell models and patient-relevant brain organoids. Founded in 2020, the company leverages these advanced biological models for AI-native drug discovery to accelerate the development of life-changing therapies.
Biotechnology
Nerai Bioscience AG is a biotechnology company headquartered in Zurich, Switzerland, that is focused on redefining genetic medicine.
Life Sciences
Rejuveron Life Sciences AG is a biotechnology company headquartered in Schlieren, Switzerland, focused on developing innovative therapeutics and therapies for aging-related diseases and longevity.
Biotechnology
Cellvie AG is a biotechnology company based in Zurich, Switzerland, pioneering Therapeutic Mitochondria Transplantation to target cellular energy metabolism.
Biotechnology
Ultimate Medicine AG is a Swiss preclinical biotechnology company headquartered in Zürich, focused on maximizing the healthspan of patients with Alzheimer's disease and other dementias by targeting novel toxic metabolites.
Biotechnology
ProJenX, Inc. is a clinical-stage biotechnology company founded in 2021 and headquartered in New York City. The firm focuses on neuroscience, developing novel, brain-penetrant therapies targeting biologically defined motor neuron diseases such as ALS. It advances research programs aimed at addressing severe neurodegenerative conditions.
Similar biotech company
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Biotechnology
Neurona Therapeutics Inc. is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.
Biotechnology
Sironax is a biopharmaceutical company committed to developing new treatments by targeting underlying contributors of degeneration, including neurodegenerative, inflammatory, and metabolic disorders.
Life Sciences
EXCIVA GmbH is a privately held biotechnology company established in 2016 in Heidelberg, Germany, focused on developing clinical-stage therapeutics to improve quality of life and treat Alzheimer's disease.
Biotechnology
Theranexus (THX Pharma) is a clinical-stage biopharmaceutical company that develops innovative therapeutic solutions for patients suffering from rare neurological diseases such as Batten disease, Niemann-Pick type C, and Gaucher disease. The company utilizes scientific research and antisense oligonucleotides to create targeted drug candidates addressing significant unmet medical needs.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of NewcelX Ltd. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for NewcelX Ltd.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →